Skip to main content
. 2022 Jan 7;36(2):e24212. doi: 10.1002/jcla.24212

FIGURE 1.

FIGURE 1

Workflow of metabolomics for metabolomic profiling and data interpretation of serum samples from HER2‐positive breast cancer and normal control